New chemical entity for minimizing cognitive impairment resulting from dronabinol.

  • Maldonado, Rafaek (Principal Investigator)
  • McCormick, Peter (Principal Investigator)
  • Puigdellivol Canadell, Maria (Co-Investigator)

Project Details

StatusFinished
Effective start/end date1/06/1631/05/17

Funding

  • Rhodes Pharmaceuticals: £11,792.00